Dr. P. Hande Ozdinler

Associate Professor

PhD: LSU/Health Sciences Center

Dr. Ozdinler received training in the fields of molecular biology, genetics, biotechnology, cell biology, anatomy and neuroscience. She is the recipient of Harvard NeuroDiscovery Center and NUCATS Translational Innovation awards. She was recruited to be the founding director of the 2nd Les Turner ALS Laboratory at Northwestern, which focused on the biology and pathology of upper motor neurons. She is now a faculty member to the Chemistry Life Sciences Processes Institute, Les Turner ALS, Mesulam Center for Cognitive Neurology and Alzheimer's Disease, and Robert H. Lurie Comprehensive Cancer Research Centers.

Dr. Richard B Silverman

B.S.: Pennsylvania State University 1968

Ph.D.: Harvard University 1974

Richard B. Silverman teaches organic chemistry, medicinal chemistry, and enzyme chemistry and carries out research in the area of medicinal chemistry, particularly related to potential treatments for neurodegenerative diseases. Silverman received his PhD in organic chemistry from Harvard University in 1974. After two years as a NIH postdoctoral fellow at Brandeis University, he joined the chemistry faculty at Northwestern University. Silverman has published 240 research articles, holds 39 domestic and foreign patents, and has written four books. He is the inventor of LyricaTM (pregabalin), a blockbuster drug marketed worldwide by Pfizer for refractory epilepsy, neuropathic pain, fibromyalgia, and (in Europe) for generalized anxiety disorder. His current research interest includes investigations of the molecular mechanisms of action, rational design, and syntheses of potential medicinal agents. The primary focus is basic research into central nervous system disorders, including Parkinson’s disease, cerebral palsy, amyotrophic lateral sclerosis, addiction, and epilepsy.

Register Now

Contact

News & Publications

Follow us

Shop Swag